Bohui Innovation (300318)
Overview
Beijing Bohui Innovation Biotechnology Group Co., Ltd. engages in the research and development, production, sale, and after-sale service of diagnostic products in China. The company offers human immunoglobulin for rabies, tetanus, hepatitis B, and intravenous injections; albumin; human prothrombin complex; and vaccine for rabies. It also provides molecular platform, such as Automatic Real-time Fluorescent Nucleic Acid Cartridge Analyzer(BHQ-III), and GenPlex BHF-VI Nucleic Acid Chip Analyzer; Tr
Market Cap$3.9B
Revenue$812.8M
Listed OnShenzhen Stock Exchange
Ticker300318
CEOMr. Zhiwei Shen
HeadquartersBeijing